Utide is a specialized manufacturer of GLP-1 peptide APIs, operating 20,000 m² of manufacturing facilities in Zunyi, Guizhou, China. Backed by a core team with over 20 years of experience in peptide R&D, process development, and GMP-oriented manufacturing, Utide has strong expertise in route development, process optimization, and rapid scale-up for a wide range of high-demand peptide products. With the Phase II facility now operational, Utide’s total annual production capacity is expected to reach 1,500–1,800 kg this year, ensuring reliable and scalable long-term supply. Utide has successfully obtained U.S. FDA Drug Master Files (DMFs) for tirzepatide (DMF No. 042984) and retatrutide (DMF No...
